The APOE gene is the most established genetic risk factor for sporadic AD [1]; therefore, our second aim was to test whether disease-APOE single nucleotide polymorphism (SNP) interactions could be used to identify significant functional variations that differentiate aMCI subjects from healthy controls. Here, APOE is linked to Alzheimer disease.